Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 153sm-edtmp
2. Quadramet
3. Samarate(5-)-153sm, (((1,2-ethanediylbis((nitrilo-kappa-n)bis(methylene)))tetrakis(phosphonato-kappa-o))(8-))-, Pentahydrogen, (oc-6-21)
4. Samarium (153sm) Lexidronam
5. Samarium Ethylenediaminetetramethylenephosphonate
6. Samarium Sm-153 Lexidronam
7. Samarium-153 Lexidronam
8. Samarium-153-edtmp
9. Sm-edtmp
1. Quadramet
2. Cyt-424
3. 160369-78-8
4. Samarium Sm 153 Lexidronam Pentasodium
5. Quadramet (tn)
6. Samarium Sm 153 Lexidronam Pentasodium [usan]
7. Sm-153 Edtmp Pentasodium
8. 7389yr3oov
9. Samarium (153sm) Lexidronam Sodium (jan)
10. Samarium Sm 153 Lexidronam Pentasodium (usan)
11. Samarium Sm153 Lexidronam Pentasodium
12. Samarium (153sm) Lexidronam Sodium [jan]
13. Samarium Sm 153 Lexidronam Pentasodium Salt [mi]
14. Samarium (153sm) Lexidronam Pentasodium [ema Epar]
15. Samarium Sm-153 Lexidronam Pentasodium [orange Book]
16. Samarium (153sm) Lexidronam Sodium
17. Db09509
18. Samarium (153sm) Lexidronam Pentasodium
19. Samarium (153 Sm) Lexidronam Pentasodium
20. Samarium Sm 153 Lexidronam Pentasodium Salt
21. D05795
22. Q3470652
23. Samarium (153 Sm) Lexidronam Pentasodium [who-dd]
24. Pentasodium;samarium-153(3+);n,n,n',n'-tetrakis(phosphonatomethyl)ethane-1,2-diamine
Molecular Weight | 695.93 g/mol |
---|---|
Molecular Formula | C6H12N2Na5O12P4Sm |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 14 |
Rotatable Bond Count | 7 |
Exact Mass | 695.80502 g/mol |
Monoisotopic Mass | 695.80502 g/mol |
Topological Polar Surface Area | 259 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 440 |
Isotope Atom Count | 1 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 7 |
Quadramet is indicated for the relief of bone pain in patients with multiple painful osteoblastic skeletal metastases which take up technetium [99mTc]-labelled biphosphonates on bone scan.
The presence of osteoblastic metastases which take up technetium [99mTc]-labelled biphosphonates should be confirmed prior to therapy.
Analgesics, Non-Narcotic
A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS. (See all compounds classified as Analgesics, Non-Narcotic.)
V10BX02
ABOUT THIS PAGE
14
PharmaCompass offers a list of Quadramet API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Quadramet manufacturer or Quadramet supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Quadramet manufacturer or Quadramet supplier.
PharmaCompass also assists you with knowing the Quadramet API Price utilized in the formulation of products. Quadramet API Price is not always fixed or binding as the Quadramet Price is obtained through a variety of data sources. The Quadramet Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Samarium Sm 153 Lexidronam pentasodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Samarium Sm 153 Lexidronam pentasodium, including repackagers and relabelers. The FDA regulates Samarium Sm 153 Lexidronam pentasodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Samarium Sm 153 Lexidronam pentasodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Samarium Sm 153 Lexidronam pentasodium supplier is an individual or a company that provides Samarium Sm 153 Lexidronam pentasodium active pharmaceutical ingredient (API) or Samarium Sm 153 Lexidronam pentasodium finished formulations upon request. The Samarium Sm 153 Lexidronam pentasodium suppliers may include Samarium Sm 153 Lexidronam pentasodium API manufacturers, exporters, distributors and traders.
Samarium Sm 153 Lexidronam pentasodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Samarium Sm 153 Lexidronam pentasodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Samarium Sm 153 Lexidronam pentasodium GMP manufacturer or Samarium Sm 153 Lexidronam pentasodium GMP API supplier for your needs.
A Samarium Sm 153 Lexidronam pentasodium CoA (Certificate of Analysis) is a formal document that attests to Samarium Sm 153 Lexidronam pentasodium's compliance with Samarium Sm 153 Lexidronam pentasodium specifications and serves as a tool for batch-level quality control.
Samarium Sm 153 Lexidronam pentasodium CoA mostly includes findings from lab analyses of a specific batch. For each Samarium Sm 153 Lexidronam pentasodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Samarium Sm 153 Lexidronam pentasodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Samarium Sm 153 Lexidronam pentasodium EP), Samarium Sm 153 Lexidronam pentasodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Samarium Sm 153 Lexidronam pentasodium USP).